INSMED Inc financial data

Symbol
INSM on Nasdaq
Industry
Pharmaceutical Preparations
Location
700 Us Highway 202/206, Bridgewater, NJ
State of incorporation
VA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 295 % -48%
Quick Ratio 24.4 % -38.2%
Debt-to-equity -637 % +84.2%
Return On Equity 307 % -84.3%
Return On Assets -57.1 % -15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 172M shares +19.5%
Common Stock, Shares, Outstanding 167M shares +16.8%
Entity Public Float 3B USD +30.4%
Common Stock, Value, Issued 1.67M USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 155M shares +12.5%
Weighted Average Number of Shares Outstanding, Diluted 155M shares +12.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 329M USD +21.9%
Research and Development Expense 514M USD -6.45%
General and Administrative Expense 380M USD +21.2%
Costs and Expenses 1.09B USD +16.8%
Operating Income (Loss) -760M USD -14.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -800M USD -15.2%
Income Tax Expense (Benefit) 2.97M USD +96.6%
Net Income (Loss) Attributable to Parent -803M USD -15.4%
Earnings Per Share, Basic -5.39 USD/shares -2.47%
Earnings Per Share, Diluted -5.39 USD/shares -2.47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.25B USD +103%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 40.3M USD +30.2%
Inventory, Net 90.1M USD +16.4%
Assets, Current 1.42B USD +34.8%
Property, Plant and Equipment, Net 72.8M USD +17.2%
Operating Lease, Right-of-Use Asset 16.4M USD -0.43%
Goodwill 136M USD 0%
Assets 1.81B USD +25.8%
Accounts Payable, Current 51.4M USD -7.79%
Employee-related Liabilities, Current 42.2M USD +67.8%
Accrued Liabilities, Current 58.8M USD +29%
Liabilities, Current 524M USD +157%
Operating Lease, Liability, Noncurrent 11.7M USD -9.36%
Other Liabilities, Noncurrent 3.19M USD -71.4%
Liabilities 1.77B USD +11.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.83M USD -126%
Retained Earnings (Accumulated Deficit) -3.9B USD -25.9%
Stockholders' Equity Attributable to Parent 38.8M USD
Liabilities and Equity 1.81B USD +25.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -184M USD -25.8%
Net Cash Provided by (Used in) Financing Activities 3.02M USD
Net Cash Provided by (Used in) Investing Activities 295M USD +610%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 167M shares +16.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 113M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.25B USD +103%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.21M USD -29.2%
Deferred Tax Assets, Valuation Allowance 904M USD +21.3%
Deferred Tax Assets, Gross 927M USD +20.3%
Operating Lease, Liability 19M USD -12.5%
Depreciation 1.59M USD +27.2%
Payments to Acquire Property, Plant, and Equipment 4.68M USD +37.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -804M USD -15.5%
Lessee, Operating Lease, Liability, to be Paid 20.2M USD -17%
Property, Plant and Equipment, Gross 120M USD +15.5%
Operating Lease, Liability, Current 6.08M USD +46.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.22M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.7M USD +5.57%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.3%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.11M USD -55.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.11M USD -70.7%
Deferred Tax Assets, Operating Loss Carryforwards 564M USD +13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 14.8M USD +27.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 654K USD -46.3%
Additional Paid in Capital 3.94B USD +33.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5.05M USD -0.02%
Deferred Tax Assets, Net of Valuation Allowance 22.5M USD -9.35%
Interest Expense 83.4M USD +38%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%